Opendata, web and dolomites

T-GRAND-SLAM SIGNED

Translating the Global Refined Analysis of Newly transcribed RNA and Decay rates by SLAM-seq

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

Project "T-GRAND-SLAM" data sheet

The following table provides information about the project.

Coordinator
JULIUS-MAXIMILIANS-UNIVERSITAT WURZBURG 

Organization address
address: SANDERRING 2
city: WUERZBURG
postcode: 97070
website: http://www.uni-wuerzburg.de

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Germany [DE]
 Total cost 149˙564 €
 EC max contribution 149˙564 € (100%)
 Programme 1. H2020-EU.1.1. (EXCELLENT SCIENCE - European Research Council (ERC))
 Code Call ERC-2018-PoC
 Funding Scheme ERC-POC
 Starting year 2019
 Duration (year-month-day) from 2019-03-01   to  2020-08-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    JULIUS-MAXIMILIANS-UNIVERSITAT WURZBURG DE (WUERZBURG) coordinator 149˙564.00

Map

 Project objective

I propose to introduce novel analysis tools via a platform for three recently developed RNA sequencing (RNA-seq) mI propose to introduce novel analysis tools via a platform for three recently developed RNA sequencing (RNA-seq) methods (SLAM-seq, TimeLapse-seq and TUC-seq). All three methods enable the direct detection of new RNA transcribed by cells in a defined window of time within the pool of total cellular RNA. This is achieved by the introduction and subsequent detection of base-mismatches in newly transcribed RNA using RNA-seq. The ability to differentiate “new” from “old” RNA greatly increases the temporal resolution of RNA-seq experiments. In the frame of my ERC CoG grant “HERPES”, we developed a computational approach (an algorithm) termed GRAND-SLAM (Globally Refined Analysis of Newly transcribed RNA and Decay rates using SLAM-seq; patent application filed) to reliably define the relative contributions of “new” and “old” RNA. GRAND-SLAM not only directly computes the contribution of “new” and “old” RNA but also provides credible intervals that allow to judge the precision of the obtained ratios for each gene. GRAND-SLAM thereby provides novel means to identify perturbations in RNA synthesis and decay. Furthermore, GRAND-SLAM directly reduces experiment costs by eliminating the need for control samples to determine sequencing error rates. In conclusion, SLAM-seq will become the new standard for gene expression profiling worldwide and GRAND-SLAM the computational tool to analyze the respective data. Within this PoC-project, we will present the GRAND-SLAM analysis platform and prepare its introduction on the market with prospective customers in three areas: next-generation-sequencing companies, pharmaceutical industry, and research institutes. We will validate the analysis platform, improve its usability via direct testing with pilot customers, and develop our envisaged business strategy according to the feedback we will gain in the course of the project.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "T-GRAND-SLAM" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "T-GRAND-SLAM" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.1.)

EXTREME (2020)

The Epistemology and Ethics of Fundamentalism

Read More  

MOCHA (2019)

Understanding and leveraging ‘moments of change’ for pro-environmental behaviour shifts

Read More  

Regen-membrane (2019)

Pulsed Electrophoretic Deposition to give Membranes for Regenerative Medicine

Read More